Edwin Bellido, MD, MSc, is a Medical Oncologist and Clinical Investigator in the NEXT Oncology Early Drug Development Unit at Hospital Universitario Quirónsalud Madrid. Edwin Bellido, received his medical degree from the Public University of Cusco in Peru, in the upper third, and immediately after completed a master’s degree in research methodology in the area of health at the University of Salamanca, Spain. Edwin Bellido completed his medical oncology training at the Valencian Institute of Oncology in Valencia, Spain, with stays at the Gustave Roussy Hospital in France in the breast cancer unit and in the drug development and innovation unit, phase 1 trials. Edwin Bellido also developed programs related to finance in the health sector at the University of Piura in Peru and a program called “Mindset Digital” at the IESE business school. He also participated as a collaborator and professor at the Human Business School founded in Barcelona, in the field of telemedicine. Currently in the academic field Edwin won a scholarship of excellence to study the Master in Molecular Oncology at the Universidad Rey Juan Carlos. And is also leading a project of artificial intelligence in the early detection of cancer on digital biopsies. In the last years, Edwin Bellido have been focused on phase 1 trials, especially in gynecological tumors. His topics of interest include the application of new technologies in the early detection of cancer and the discovery of new biomarkers to help patients which is my underlying motivation that drives me every day.
